SUSAN BURNS: Open Payments
NPI 1144603283 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 13 payments from 9 companies in 2025. Trend: 2023 $935 · 2024 $1,357 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $247 |
| Merck Sharp & Dohme LLC | 4 | $183 |
| Mallinckrodt Hospital Products Inc. | 1 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $95 |
| PFIZER INC. | 1 | $42 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: TAVNEOS, PREVYMIS, TERLIVAZ, CAPLYTA, THYMOGLOBULIN, Auvelity, ELIQUIS, ULTOMIRIS.
Industry payments across AZ — which companies pay providers there.
